FDA Approves Mavyret for Children, Adolescents With Hep C
Drug approved for treatment of all six genotypes of hepatitis C virus in children ages 12 to 17
Read MoreFor latest News and updates
Posted by Physicians Weekly | May 1, 2019 | HealthDay |
Drug approved for treatment of all six genotypes of hepatitis C virus in children ages 12 to 17
Read MorePosted by Physicians Weekly | Oct 29, 2018 | HealthDay, Nephrology |
Donor profile index of transplanted kidneys has risen modestly in US, with greater increase in France
Read MorePosted by Physicians Weekly | Oct 26, 2018 | HealthDay, Nephrology |
Also do not correlate well with reperfusion biopsies, not linked to transplant outcomes
Read MorePosted by Physicians Weekly | Oct 17, 2018 | HealthDay, Nephrology |
Well-being and medication adherence negatively linked to psychological morbidity, dialysis
Read MorePosted by Physicians Weekly | Aug 13, 2018 | HealthDay |
Proven infections, antibiotic treatments in past three months tied to increased development of CDI
Read More